Who owns Neurocrine Biosciences?

Key details on Neurocrine Biosciences (Ticker: NBIX)

Who owns Neurocrine Biosciences?

Is NBIX a good stock to own? Find out who bought Neurocrine Biosciences, who sold Neurocrine Biosciences (NBIX) stock, and who holds a large position in Neurocrine Biosciences.

Fund Name Number of Shares Share Valuation As Of
FMR 12.97M $512.87M March 31, 2016
T. Rowe Price Associates 9.58M $378.72M March 31, 2016
Vanguard 5.94M $336.09M Dec. 31, 2015
BVF 5.93M $50.40M Dec. 31, 2011
BlackRock Fund Advisors 3.22M $127.49M March 31, 2016
BB Biotech AG 3.12M $123.46M March 31, 2016
Visium Asset Management 3.02M $119.92M March 31, 2015
Perceptive Advisors 2.72M $107.61M March 31, 2016
STATE STREET CORPORATION 2.68M $106.08M March 31, 2016
OrbiMed Advisors 2.65M $104.96M March 31, 2016
PointState Capital 2.63M $104.57M March 31, 2015
Inves 2.38M $94.24M March 31, 2016
Westfield Capital Management Company 2.29M $90.87M March 31, 2015
Janus Capital Management 2.23M $88.26M March 31, 2016
VHCP Management 2.22M $16.62M Dec. 31, 2012
Franklin Resources 2.20M $32.71M June 30, 2014